Increased lipogenesis and resistance of lipoproteins to oxidative modification in two patients with glycogen storage disease type 1a

J Pediatr. 2002 Feb;140(2):256-60. doi: 10.1067/mpd.2002.121382.

Abstract

We describe 2 patients with glycogen storage disease type 1a and severe hyperlipidemia without premature atherosclerosis. Susceptibility of low-density lipoproteins to oxidation was decreased, possibly related to the ~40-fold increase in palmitate synthesis altering lipoprotein saturated fatty acid contents. These findings are potentially relevant for antihyperlipidemic treatment in patients with glycogen storage disease type 1a.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cholesterol, LDL / metabolism*
  • Glycogen Storage Disease Type I / blood
  • Glycogen Storage Disease Type I / complications
  • Glycogen Storage Disease Type I / genetics
  • Glycogen Storage Disease Type I / physiopathology*
  • Humans
  • Hyperlipidemias / complications*
  • Lipoproteins, VLDL / metabolism
  • Male
  • Oxidation-Reduction
  • Triglycerides / blood

Substances

  • Cholesterol, LDL
  • Lipoproteins, VLDL
  • Triglycerides